← Leaderboards
Catherine H Van Poznak
University Of Michigan At Ann Arbor
$669,600
Attributed
$669,600
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $133.9K · FY2009–13$200K$150K$100K$50K$0
'09
'10
'11
'12
'13
Funding mix
By agency
NIH$669,600 · 1
By mechanism
K23$669,600 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Michigan At Ann Arbor
Same institution · by research overlap
- John V Moran$18,547,664
- Laurence H Baker$13,775,401
- Arul M Chinnaiyan$35,112,976
- David E Schteingart$4,777,133
- Kenneth M Kozloff$4,214,322
Others in their field
Top investigators on “Foundations”
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Mitchell J Malone · Texas A&M Research Foundation$353,400,900
- Gary D Acton · University Of California-Davis$320,373,312
- George R Seage · Abt Associates, Inc.$281,069,277
- Everette D Joseph · Howard University$268,880,223
- Valerie Koch · University Corporation For Atmospheric Res$265,601,376
Research focus
FoundationsApplications GrantsBiomarkerAwardBoneBaseBone NecrosisCancer CareBisphosphonateCase ControlCase-Control StudiesCharacteristicsBone DiseasesClinical Trials DesignDatabasesDentistsDisseminated Malignant NeoplasmEnzymesCareer DevelopmentEthicsEtiologyEventFormalinFracture
Grant awards (5)
Genetic Risk of Osteonecrosis of the Jaw (ONJ) in Patients with Metastatic Cancer$133,920
K23 · FY2013 · DE · contact PI
Genetic Risk of Osteonecrosis of the Jaw (ONJ) in Patients with Metastatic Cancer$133,920
K23 · FY2012 · DE · contact PI
Genetic Risk of Osteonecrosis of the Jaw (ONJ) in Patients with Metastatic Cancer$133,920
K23 · FY2011 · DE · contact PI
Genetic Risk of Osteonecrosis of the Jaw (ONJ) in Patients with Metastatic Cancer$133,920
K23 · FY2010 · DE · contact PI
Genetic Risk of Osteonecrosis of the Jaw (ONJ) in Patients with Metastatic Cancer$133,920
K23 · FY2009 · DE · contact PI